SBI Healthcare Opportunities Fund
Sectoral · Direct Growth Very High Risk
₹580.1818
NAV on 28-Oct-2026
Showing the Direct plan. The Regular plan you picked has the same portfolio but a higher expense ratio, so its NAV and returns are lower.
Fund size (AUM)
₹5,870 Cr
Expense ratio
1.00%
Since inception (CAGR)
+17.80%
Minimum SIP · lump sum
₹500 · ₹5,000
Returns
absolute up to 1Y, annualised beyond| 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|---|
| This fund | -2.74% | -0.91% | +15.05% | +15.87% | +24.15% | +18.98% | +14.56% |
| Category average | — | -4.89% | +7.29% | +6.47% | +20.21% | +14.60% | — |
About
| Fund house | SBI Mutual Fund |
| Fund managers | Tanmaya Desai |
| Benchmark | BSE Healthcare Total Return Index |
| Launched | 01-Jan-2013 |
| ISIN | INF200K01UP2 |
| Exit load | Exit load of 0.50% if redeemed within 15 days |
Risk
| Standard deviation | 14.77 |
| Sharpe ratio | 1.10 |
| Sortino ratio | 1.91 |
| Alpha | 3.08 |
| Beta | 0.87 |
Top holdings
38 in total| Holding | Sector | Value | % of fund |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | ₹654 Cr | 11.14% |
| Divi's Laboratories Ltd | Healthcare | ₹465 Cr | 7.91% |
| Repo | Unspecified | ₹377 Cr | 6.42% |
| Ami Organics Ltd | Healthcare | ₹295 Cr | 5.03% |
| Apollo Hospitals Enterprise Ltd | Healthcare | ₹261 Cr | 4.45% |
| Torrent Pharmaceuticals Ltd | Healthcare | ₹259 Cr | 4.42% |
| Cipla Ltd | Healthcare | ₹258 Cr | 4.40% |
| Laurus Labs Ltd | Healthcare | ₹238 Cr | 4.05% |
| Max Healthcare Institute Ltd | Healthcare | ₹223 Cr | 3.80% |
| Aurobindo Pharma Ltd | Healthcare | ₹201 Cr | 3.42% |
| Aster DM Healthcare Ltd | Healthcare | ₹188 Cr | 3.21% |
| Gland Pharma Ltd | Healthcare | ₹174 Cr | 2.96% |
| Sudeep Pharma Ltd. | Healthcare | ₹164 Cr | 2.79% |
| Anthem Biosciences Ltd. | Healthcare | ₹161 Cr | 2.75% |
| Sai Life Sciences Ltd. | Healthcare | ₹152 Cr | 2.60% |
| CORONA Remedies Ltd. | Healthcare | ₹142 Cr | 2.43% |
| Biocon Ltd | Healthcare | ₹139 Cr | 2.37% |
| Fortis Healthcare Ltd | Healthcare | ₹139 Cr | 2.36% |
| Concord Biotech Ltd. | Healthcare | ₹132 Cr | 2.25% |
| Aether Industries Ltd | Materials | ₹127 Cr | 2.17% |
Fetched 29 Oct, 17:40 IST. Past returns don't predict future returns. Source: Indian Stock API.